Bovine papillomavirus type 1 E2 and E7 proteins down-regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts.

This research paper investigates how Bovine papillomavirus type 1 (BPV-1), a virus implicated in the formation of skin tumors in horses, suppresses the immune response by reducing the expression of Toll Like Receptor 4 (TLR4) in horse fibroblast cells.

Research Background and Methods

• The study expands on previous research where the authors identified changes in gene expression in horse fibroblasts induced by BPV-1 using microarray analysis, a technique that allows for the simultaneous examination of thousands of genes.
• The central focus of this research is on the expression of the Toll Like Receptor 4 (TLR4), a type of protein that play a crucial role in the immune system by helping recognize and respond to pathogens. Specifically, the researchers observed that BPV-1 significantly reduces the expression of TLR4.

Findings and Results

• Through further experiments, the researchers confirmed their observation: the introduction of BPV-1 E2 and E7 proteins in primary horse fibroblasts significantly reduced TLR4 expression.
• This finding was validated by another experiment where they increased TLR4 expression by suppressing the effects E2 and E7 proteins—specific genes of BPV-1—using small interfering RNAs (siRNAs), molecules that can interfere with the expression of specific genes.

Implications and Conclusion

• The research makes an important contribution to understanding the relationship between BPV-1 and the host’s immune response. The data suggests that the virus employs a strategy to evade the host’s immune system by downregulating TLR4, which could help the virus persist and cause skin tumors in horses.
• These findings could open up potential avenues for the development of new intervention strategies targeting the effects of BPV-1 on TLR4 to manage or prevent the development of skin tumours in horses.